- Email Preferences
- Logout

+44 (0)20 8762 8008
Change Language
[Close]
- English
  
  Japanese
  
  English
Home
Overview
- Pandemic
- Bird Flu
Subscribers
Locations
Newsroom
- News
- Editorials
- FAQs

Quick Links

COVID-19

Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

Member Access

Travel Restrictions, Flight Operations and Screening

COVID-19 Digital Passports

Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID-19 Vaccine FAQs

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice

COVID-19 Disease and Prevention Article

Sign up for Emails and Alerts

Premium Services Member Access

COVID-19 Manager Advice

COVID-19 Case Definitions used by different authorities

Pandemic Local Impact Tool

COVID-19 Communication Material

COVID-19 Modelling

COVID-19 Useful Links

…
18
19
20
21
22
…

Moderna gains full regulatory approval
United States // 05 February, 2022
Second vaccine to do so…
COVID-19
Interim authorisation granted for Paxlovid
Singapore // 03 February, 2022
First oral treatment of COVID-19 approved for use in Singapore...
COVID-19
Vaccine Update - Booster dose approved for some people
Libya // 03 February, 2022
Booster shot approved for people above 50...
COVID-19
Study highlights challenges with interpreting at-home COVID-19 test results
United States // 03 February, 2022
Adults may struggle to interpret and act upon at home COVID-19 test...
COVID-19
Community transmission of COVID-19
Tonga // 02 February, 2022
The first cases of COVID-19 acquired within Tonga....
COVID-19
CDC updates guidance on the use of respirators
01 February, 2022
People can choose to use N95s now that shortages are not a concern.....
COVID-19
Pfizer/BioNTech seeks FDA approval for paediatric dose
United States // 01 February, 2022
Advisory committee to meet 15 February…
COVID-19
Novavax seeks FDA approval
United States // 31 January, 2022
Fourth vaccine for the US if approved…
COVID-19
Moderna gets FDA approval
United States // 31 January, 2022
Second COVID-19 vaccine to receive full authorisation in adults…
COVID-19
Vaccine update - Pfizer/BioNTech vaccine open to 12 to 17 year olds
Malawi // 31 January, 2022
COVID-19 vaccination expanded to 12 years and older
COVID-19
Vaccine Update – Pfizer/BioNTech approved for children aged 5 to 11 years
Qatar // 31 January, 2022
Health authorities have approved Pfizer/BioNTech to be used in children aged 5 to 11 years...
COVID-19
COVID-19 from pet hamster and onward transmission
Hong Kong (China SAR) // 30 January, 2022
COVID-19 transmission from hamsters to humans and onward spread
COVID-19
Hypotheses of Omicron origin
30 January, 2022
Theories on origin of Omicron
COVID-19
ECDC updates guidance on ending isolation for people with COVID-19
29 January, 2022
Focus on Omicron transmission and shortening isolation....
COVID-19
Vaccinating parents may protect children from COVID-19
29 January, 2022
Parental vaccination confers protection to unvaccinated children against COVID
COVID-19
Omicron Sub-Lineage BA.2 update
Denmark // India // South Africa // United Kingdom // 28 January, 2022
The variant is increasing in Denmark, India, South Africa and the United Kingdom....
COVID-19
Higher risk of rehospitalisation and death following COVID-19 hospitalisation
28 January, 2022
People hospitalised due to COVID-19 are at a higher risk of rehospitalisation and death compared to general population
COVID-19
COVID-19 vaccine update - Different vaccine brand as booster dose
Nepal // 28 January, 2022
Brand other than vero cell can be used as booster
COVID-19
Third doses protect against hospitalisation
United States // 27 January, 2022
CDC study examines benefits of mRNA vaccine…
COVID-19
European Medicines Agency recommends conditional approval for Paxlovid
27 January, 2022
EMA recommends conditional approval for Paxlovid...
COVID-19

…
18
19
20
21
22
…

Additional data provided by

© 2024 International SOS